have the potential to improve aspects of the dynamic V O 2 response during exercise by enhancing endothelial function and, hence, have a positive effect on performance. In addition, cyanidin-3-glucoside, an anthocyanin found in abundance in MC concentrate, 3 has been shown to increase eNOS expression and decrease inducible NO synthase (iNOS) expression. 14 Such changes in the balance between eNOS and iNOS expression/activity would favor the bioavailability of the vasoactive NO. Therefore, if MC does increase NO bioavailability, it is possible that muscle O 2 delivery and/ or its intramuscular distribution might be enhanced which, in turn, could be advantageous at the onset of exercise and during maximal exercise. Further to these mechanisms, other polyphenol compounds such as quercetin (which is reported to be present in MC 15 ) bind and antagonize the adenosine receptor, which could improve performance in a caffeine-like manner. 16 Similarly, MC concentrate is rich in AOX compounds that also have the potential to augment performance. 17 Despite the potential vasodilatory and AOX properties of tart cherries, only 2 studies have investigated the effect of tart Montmorency cherry supplementation on continuous exercise capacity and performance. Clifford et al 18 investigated the influence of different sources of polyphenols on submaximal cycling and time-trial performance. Supplementation with 200 mg of dried Montmorency cherry capsules for 3 days did not improve cycling time-trial performance, heart rate, respiratory exchange ratio, gross mechanical efficiency, oxygen consumption, or blood [lactate] in moderately trained cyclists (VO 2peak 52.4 ± 8.7 mL/kg/min). In contrast, when participants were supplemented with powdered tart cherry capsules for 10 days, half-marathon completion times were 13% faster than their placebo counterparts, 19 although the mechanism for this improvement remains unclear. It should be noted that the actual race pace was slower compared to the projected race pace in both groups, but the difference tended to be smaller in the tart cherry group compared to the placebo group. Furthermore, the authors of this study acknowledged that the participants were matched based on average reported race pace, and therefore, there might be some variability among groups. As a result, further studies with a strong study design are needed to evaluate whether supplementation with tart cherries can provide benefits to exercise performance. Similar performance-enhancing findings have been reported in other studies where polyphenolic content of a fruit-derived supplement is similar to tart cherries. 20, 21 Kang et al 20 reported that oligomerized lychee fruit extract increased the anaerobic threshold by 7.4%. More recently, Cook et al 21 reported that, following a 7-day intake of New Zealand blackcurrant extract, there was an improvement in cycling time-trial performance by 2.4%. The authors speculated that this improvement might have been the result of improved endothelial function and increased peripheral blood flow. Conversely, in another study, 22 supplementation with a polyphenol antioxidant for 1 week failed to improve exercise performance, cardiovascular function, and thermoregulatory control in well-trained cyclists. The lack of improvement in exercise performance may be related to the training status of the subjects, exercise modality, and/or the experimental conditions under which performance was assessed.
Although the potential beneficial role of MC in expediting exercise recovery has been unequivocally demonstrated, 23, 24 it is still unclear whether acute MC supplementation can improve endurance exercise performance. Given that most polyphenol compounds are either absorbed or excreted quickly, 9, 10, 25 longer-term (10-day) supplementation periods 19 may not be necessary to observe improvements in performance. Furthermore, the potential mechanisms that might underpin any ergogenic effects of MC consumption are yet to be fully resolved. Therefore, the purpose of this study was to investigate the effects of acute MC supplementation on plasma NO 2 − concentration ([NO 2 − ]), a sensitive marker of NOS activity, 26 as well as blood pressure, V O 2 kinetics, muscle oxygenation, and exercise performance using a doubleblind, crossover experimental study design. We also used near-infrared spectroscopy to provide insight into the matching between skeletal muscle O 2 delivery and utilization 27 and, therefore, the potential underlying mechanisms for improvement in V O 2 kinetics or exercise performance following MC supplementation.
| METHODS

| Participants
Eleven trained male cyclists volunteered to take part in the study, but 1 participant withdrew after the second study day (mean ± SD age; 28 ± 7 years, stature 1.83 ± 0.06 m, body mass 78.0 ± 8.5 kg, and V O 2peak 59.0 ± 7.0 mL/kg/ min). Exclusion criteria for the study were as follows: V O 2peak <50 mL/kg/min (determined on visit 1), smoking, food allergy (as discussed with research team), history of gastrointestinal, renal or cardiovascular disease, and current use of any food supplementations. All participants provided
written, informed consent prior to the commencement of the study. For 24 hours prior to and for each of the testing days, participants were asked to avoid strenuous exercise, alcohol, caffeine, nutritional supplements, and any anti-inflammatory drugs. Participants were instructed to follow a low phenolic diet for 24 hours prior to each arm of the trial by avoiding fruits, vegetables, tea, coffee, alcohol, chocolate, cereals, wholemeal bread, grains, and spices and were asked to refrain from strenuous exercise. Compliance with the dietary restrictions was monitored with a standardized, self-reported dietary record. Participants were asked to arrive at the laboratory in a rested and fully hydrated state, ≥10 hour postprandial. All tests were performed at the same time of day. The study was conducted in accordance with the Helsinki Declaration and ratified by the University's Research Ethics Committee.
| Study design
Participants were required to report to the laboratory on 5 occasions over a 4-to 5-week period to complete the experimental testing (1 familiarization/VO 2peak visit and 4 experimental visits). On the first visit to the laboratory, participants completed a ramp incremental exercise test for determination of the gas exchange threshold (GET) and peak V O 2 (VO 2peak ). Participants were also familiarized with the 2 exercise performance tests employed in the study on this visit to avoid any order effect on the performance results as a consequence of a potential "learning effect". Participants then returned to the laboratory on visits 2, 3, 4, and 5 to complete the experimental testing (MC × 2 trials, Placebo (PLA) × 2 trials). During these tests, resting blood pressure, arterial stiffness, pulmonary V O 2 kinetics during moderate and severe-intensity exercise, muscle oxygenation, and exercise performance were assessed, and venous blood samples were obtained. The MC concentrate and PLA drinks were administered in a randomized order as part of a double-blind, crossover experimental design. Each supplementation day was separated by at least 3 days, but no more than 7 days.
| Incremental test
During the first laboratory visit, participants completed a ramp incremental cycle test on an electronically braked cycle ergometer (Lode Excalibur Sport, Groningen, the Netherlands). Initially, participants performed 3 minutes of baseline cycling at 0 W, after which the work rate was increased by 30 W/min until the limit of tolerance. The participants cycled at a self-selected pedal rate, which, along with saddle and handlebar heights and configuration, was recorded and reproduced in subsequent tests. Breath-bybreath pulmonary gas exchange data were collected continuously during the incremental tests and averaged over consecutive 10-seconds periods. Following the incremental test and a 45-minute rest, participants were familiarized with the exercise tests. Participants completed a moderate-intensity and severeintensity step test finishing with an all-out sprint followed (after a 30-minute passive recovery period) by a severeintensity constant-work-rate step exercise test to the limit of tolerance.
| Experimental tests
On all subsequent visits, participants were required to rest in a seated position for 10 minutes in an isolated room. Thereafter, baseline blood pressure of the brachial artery was measured using an automated sphygmomanometer (M10-IT Omron Healthcare, UK) according to British Hypertension Society guidelines. Additionally, pulse wave velocity and pulse wave analysis were determined using arterial tonometry (SphygmoCor CPV system, ScanMed Medical, UK). Three measurements were taken, and the mean of the measurements was calculated. A venous blood sample was then collected into a lithium-heparin tube and centrifuged at 1431 g at 4°C for 10 minutes, within 2 minutes of collection. Lithium-heparin plasma was subsequently extracted and immediately frozen at −80°C for later analysis of [NO 2 − ] in duplicate via ozone-based chemiluminescence.
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Participants were then provided with standardized breakfast. Descriptive measures and a physical activity level of 1.7 were used to calculate the participant's individual resting energy expenditure (Schofield Equation, 1985) . This subsequently identified the amount of cereal (Rice Snaps, Tesco, Manchester, UK) and semiskimmed milk (1 g/kg/bm) each individual needed to consume to meet 10% of their daily energy requirements. This standardized fixed-energy breakfast meal consisted of a cereal: milk ratio of 30 g: 120 mL and delivered fat, protein, and carbohydrate with a macronutrient composition of 14%, 14%, and 72%, respectively. 30 One hour post-breakfast consumption, participants received the intervention drink. Ninety minutes after ingestion of the supplement, vascular measures were reassessed and participants completed 1 of the 2 cycle tests described below, as published pharmacokinetic data have shown that this time frame should coincide with peak plasma concentrations of phenolic acids following MC supplementation.
9,11
The exercise protocol consisted of 3 "step" exercise tests including 2 moderate-intensity step tests followed by 1 severeintensity exercise bout. All participants performed a total of 4 bouts of moderate-intensity exercise and 2 bouts of severeintensity exercise for each experimental condition; this protocol replicated previous work. 30 Each transition began with 3 minutes of baseline cycling at 20 W before an abrupt transition to the target work rate. Each moderate-intensity bout lasted 6 minutes. A passive recovery of 5 minutes separated the transitions. On 2 of the study visits (1 occasion for each supplement), participants cycled for 6 minutes at a severeintensity constant work rate (70% Δ), followed immediately by a 60-seconds all-out sprint at maximum effort. The resistance on the pedals during this sprint was set using the linear mode of the Lode ergometer, so that each participant would attain the power output calculated to be 50% Δ when considering the participants preferred cadence (linear factor = power/preferred cadence 2 ). Participants were provided with a 5-seconds countdown prior to the sprint. On the other 2 study visits (1 occasion for each supplement), the severe-intensity constant-work-rate bout was continued to the limit of tolerance. The time to task failure was used as a measure of exercise tolerance and was immediately recorded when the pedal rate fell by >10 rpm below the required pedal rate.
| Treatments and dietary control
Participants consumed either 60 mL of commercially available MC concentrate (CherryActive ® , Hanworth, UK) or fruit-flavored cordial in a double-blind, crossover manner. The choice to use 60 mL was based on previous work that showed a greater uptake of anthocyanin and phenolic acids in vivo post-consumption when compared to a 30 mL dose. 3, 9, 11 The concentrate was diluted with 100 mL of water prior to consumption. The PLA supplement consisted of a commercially available, low fruit (<1%) cordial (Kia Ora, Coca-Cola Enterprises, Uxbridge, UK) mixed with water, whey protein isolate (Arla Foods Ltd., Leeds, UK), and maltodextrin (Myprotein Ltd., Northwich, UK), to match the MC concentrate for volume and macronutrient content (energy = 204 kcal, volume = 60 mL, carbohydrates = 49 g, protein = 2.2 g, and fat = 0 g). Prior to study commencement, it was explained to participants that the aim of the study was to investigate the effect of a fruit juice on vascular function. As a result, they were unaware which beverage was the experimental drink. There were no adverse events reported in response to the intervention products. Subjects consumed all doses of the supplement for each experimental condition, and all participants complied with the low-polyphenolic experimental diet according to the food diaries.
| Measurements
During all tests, pulmonary gas exchange and ventilation were measured breath-by-breath. Participants wore a nose clip and breathed through a low-dead-space, low-resistance mouthpiece-and-impeller turbine assembly. Following calibration, according to manufacturer's recommendations, the inspired and expired gas volume was continuously sampled at 100 Hz; gas concentration signals were continuously sampled at 100 Hz using paramagnetic (O 2 ) and infrared (CO 2 ) analyzers (Oxycon, Care Fusion, Rolle, Switzerland). For data analysis, the moderate bouts of exercise were exported in 10-seconds averages and then averaged for all bouts. Endexercise V O 2 (average over the last 30 seconds and 60 seconds of the bout), baseline V O 2 (average over the 60 seconds prior to exercise), and the amplitude (the difference between the end-exercise and baseline V O 2 ) were analyzed. For the severe bouts of exercise, the data were exported in 10-seconds averages and then all bouts were averaged. Baseline V O 2 (average over the 60 seconds prior to exercise), the V O 2 at 120 seconds (the average from 110 seconds to 130 ie, 120 seconds ± 10 seconds), and the end-exercise V O 2 (the average over the last 30 seconds of the bout) were identified. The peak V O 2 was identified using the end-exercise V O 2 . Furthermore, the difference between the baseline and 120-seconds V O 2 provides a surrogate for the fundamental amplitude, while the difference between V O 2 at 120 seconds and end-exercise (exhaustion) was used as a surrogate of the V O 2 slow component.
The oxygenation status of the vastus lateralis of the right leg was monitored by near-infrared spectroscopy system (NIRS; INVOS 5100C, Somanetics, Troy, MI, USA) at 2 different wavelengths (765 nm and 855 nm). The intensity of the transmitted light was continuously recorded at 1 Hz. Based on the absorption and scattering coefficients of light at each wavelength, determined by Beer-Lambert Law, concentrations were estimated for oxy (HbO 2 ), deoxy (HHb), and total hemoglobin. The leg was initially cleaned around the belly of the muscle, and the optodes were placed 20 cm above the fibular head. The probes were secured to the skin surface and covered with an elasticized, tensor bandage to minimize the influence of extraneous light, and to avoid movement of the probe relative to the skin while allowing unrestricted movement. The NIRS data were acquired continuously throughout the exercise protocol and output every 5 seconds and recorded for later offline analysis. The NIRS data output was time-stamped at the start of each task segment to assure that data corresponded to the relevant period of task performance. To provide information on muscle oxygenation, NIRS data were averaged at the time points of interest, and relative concentration changes in HbO 2 and HHb were calculated.
The tissue oxygenation index (TOI) was calculated using the following equation 30 Pulse wave velocity (PWV) and pulse wave analysis (PWA) were determined using arterial tonometry (SphygmoCor CPV system, ScanMed Medical, UK). The aortic pulse waveform and augmentation index were derived at the radial artery, and PWV was determined between carotid and femoral sites. A pencil-type probe was used for all measurements and was held at the base of the neck over the carotid artery and at the inguinal crease over the right femoral artery. Recordings were taken when a reproducible signal was obtained with a high-amplitude excursion. The distance between carotid and femoral sites was measured, and electrocardiogram gating permitted the time lapse between pulse waves at the carotid and femoral sites to be calculated. Intertrial and intratrial % coefficient of variation (CV) for this method were 3.3% and 3.1%, respectively.
During the exercise trials, a blood sample was collected from a fingertip into a capillary tube at baseline, over the 20 seconds preceding the step transition in work rate, the 20 seconds preceding the completion of 360 seconds of moderate-and severe-intensity cycling exercise, immediately following the 60-seconds all-out sprint, and immediately after exhaustion during the severe-intensity constant-work-rate trial. These whole blood samples were analyzed to determine blood lactate (Biosen C_Line, EKF Diagnostic, Barleben, Germany). Intrasample CV for this instrument was 1.8%. 
|
| Statistical analysis
Statistical analysis was performed using PASW Statistics 21.0 for Windows (SPSS, Inc., Chicago, IL.). All group characteristics were reported as means ± standard deviations unless otherwise stated. A 2 (MC vs PLA) × 2 (pre vs post) repeated measures analysis of variance (ANOVA) was employed to assess between-intervention differences in V O 2 , NIRS-TOI, blood pressure, arterial stiffness, and lactate. Mauchly's test of sphericity was used to check homogeneity of variance for all ANOVA and where necessary, violations of the assumption were corrected using the GreenhouseGeisser adjustment. Significant main effects were followed up using LSD post hoc analysis. Exercise performance and NO 2 − and NO 3 − were analyzed using a paired samples t test. Statistical significance was accepted when P < .05.
| RESULTS
Eleven physically active males volunteered to take part in the study, but 1 participant voluntarily withdrew after the second study day (n = 10).
| Pulmonary V O 2 kinetics
The pulmonary V O 2 data for the moderate-and severeintensity cycle tests are reported in Table 1 . There were no significant between-supplement differences for the baseline and end-exercise V O 2 during the moderate-intensity step exercise tests (P > .05). Accordingly, the fundamental V O 2 amplitude was not significantly different between the conditions (0.55 ± 0.09 and 0.60 ± 0.07 L/min with MC concentrate and PLA, respectively, P > .05).
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The baseline and end-exercise V O 2 during severeintensity exercise were not significantly impacted by the dietary interventions employed in this investigation (P > .05 for all comparisons). The V O 2 at exhaustion was not significantly different between experimental conditions and was also not significantly different from the V O 2peak attained in the ramp incremental test (P > .05). No significant differences were reported between MC and PLA in V O 2 amplitudes from baseline to 120 seconds of exercise. No differences in V O 2 slow component were observed across the experimental conditions (Table 1 ). There were no differences in V CO 2 between the conditions during moderate-or severe-intensity cycle exercise (P > .05 for all comparisons).
| Exercise performance
The time to exhaustion during the severe-intensity constantwork-rate cycle trials (the exercise tolerance test) is presented in Figure 1 ; while the power profiles for the 2 experimental conditions during the 60-seconds all-out sprint that followed the 6-minutes bout of severe-intensity exercise (the exercise performance test) are presented in Figure 2 . There were no significant differences in time to exhaustion during the exercise tolerance test between the MC (772 ± 34 seconds) and the PLA conditions (733 ± 34 seconds, P = .323). A significant main effect for supplement was observed for the peak power over the first 20 seconds, and total work completed during the 60-seconds all-out sprint that followed the 6-minutes severe-intensity pre-load (P < .002). Follow-up analyses demonstrated that, compared with PLA, MC concentrate supplementation increased the test peak power by 9.5% (363 ± 42 vs 330 ± 26 W, P = .034; Figure 2 ) and the total work completed during the 60-seconds sprint by 10% between conditions (21 ± 3 vs 19 ± 3 kJ, P = .021).
| NIRS
The tissue oxygenation index data during moderate-and severe-intensity cycle exercise with PLA and MC supplementation are reported in Table 2 . There were no significant differences between the experimental conditions during the moderate-or severe-intensity exercise (P > .05).
| Vascular measures
There was a significant interaction effect for supplement on SBP (P < . Table 4 . There were no changes for NO 2 − or NO 3 − in the MC-supplemented trial when compared to the placebo (P > .05).
| Lactate
There was no treatment or treatment × time interaction effect observed in blood [lactate]; however, there was a significant time effect identified during both the exercise performance and tolerance test (P < .001). No other differences were reported. Absolute values are presented in Table 5 .
| DISCUSSION
The principal novel findings from this study are that, compared with an energy-matched placebo, acute MC 
| Influence of MC supplementation on performance
In the current study, peak power output and total work done during a 60-seconds sprint increased by 9.5% and 10%, following MC relative to the PLA supplementation. While tart cherry supplementation has been shown to improve exercise recovery 23, 24 and decrease markers of inflammation and oxidative stress, 1,3 studies investigating the effects of tart cherries on exercise performance are limited and equivocal. Of the 2 studies investigating the influence of MC supplementation on exercise performance to date, 1 reported improved performance in males completing a half-marathon (21.1 km) run, as evidenced by a faster overall race pace compared to the PLA group. 19 However, as previously mentioned, there
were some limitations to the study design, and therefore, these results should be interpreted with a degree of caution. While Levers et al 19 designed an experiment to assess the influence of ingesting 480 mg of powdered tart cherries for 10 days, including supplementation on race day up to 48 hour post-run, we investigated the effects of a single dose (60 mL) of MC concentrate on exercise performance using a crossover study design. Despite the differences in dosing strategies, both studies reported improvements in performance. Therefore, our findings suggest that acute as well as chronic supplementation with MC concentrate has the potential to improve performance, specifically end-sprint performance.
Conversely, an earlier study by Clifford et al 18 reported no difference in time-trial performance in moderately trained individuals following the ingestion of 200 mg of powdered tart cherries for 3 days. These conflicting findings might be due to the differences in dosing procedures (480 mg vs 200 mg) and exercise tests performed (20 km cycling time-trial vs half-marathon). The current investigation used a MC concentrate as opposed to the powdered capsules used in both previous studies. The MC concentrate was found to contain 73.50 ± 0.20 mg cyanidin-3-glucoside/L and 178.75 ± 0.87 mean gallic acid equiv/L. 11 The exercise protocol used in the current study also differed to the 2 previous studies. There were no differences observed for time to exhaustion between the MC and the PLA trial in the current study. Trinity et al 22 also reported that polyphenol supplementation did not improve performance during prolonged exhaustive exercise (1 hour of exercise including a 10-minutes timetrial) or during shorter duration high-intensity exercise (time to fatigue at VO 2max ). There remains a debate surrounding the applicability and repeatability of the time to exhaustion test as there is a larger day-to-day variability when compared to a time-trial. 31 However, a recent addition to the literature concluded that a time to exhaustion test is regarded as a more useful measure of cycling performance compared to a time-trial. Given that MC concentrate has been shown to possess numerous AOX and polyphenolic compounds, 1,2 it seems reasonable that the improvement in exercise performance in the current study might be as a result of these AOX compounds. It is worth noting that MC supplementation could have prolonged the duration for which the participants were in the optimal cellular redox state for force production 36 such that when they were required to produce an all-out sprint, they produced a higher peak power and completed more work. In addition, muscle blood flow is considered an important limiting factor during high-intensity exercise, 37 and it is possible that the improvement in exercise performance might be linked, in part, to an increase in blood flow. Previous research has demonstrated the vasodilatory effects associated with anthocyanin intake, 38 and more recently, MC supplementation has been shown to alter vascular function and behavior. 26 As trained endurance cyclists were recruited in the current study, and as endurance training increase NOS expression, 39 it is likely that eNOS-derived NO production was already optimal in this cohort, and therefore, no changes were observed after MC supplementation. It is also noteworthy that the resting plasma [NO 2 − ] was relatively low in the current study when compared with previous literature. 40 This could be as a result of the dietary restrictions imposed on the participants on the day preceding the trial and/or a low intake of nitraterich foods in the period leading into the trials.
| Influence of MC supplementation on blood pressure
A primary outcome of enhanced NO synthesis is a reduction in blood pressure owing to NO-induced smooth muscle relaxation. 41 The current study reported a significant reduction in SBP 1.5 hour post-MC ingestion relative to placebo; however, this augmented modulation occurred in the absence of changes in NO biomarkers. These results are consistent with a recent study demonstrating that supplementation with the NOS substrate, L-citrulline, 40 lowered blood pressure in the absence of a change in plasma [NO 2 − ]. Mechanistically, it would appear that the lowering of BP with acute MC supplementation in the current study is largely NO-independent and is more likely to be a function of the increase in circulating phenolic metabolites post-MC ingestion. 11 There was no change in arterial stiffness observed in the current study. This observation is in line with previous studies reporting improved SBP following MC consumption in males with early hypertension 11 and middle-aged adults, 10 with no improvement in arterial stiffness. It has previously been reported that concurrent improvements in all measures of vascular function are not always observed. 11 Further research is required to investigate the mechanisms by which MC supplementation might positively affect vascular and other physiological responses.
A limitation of the current study is the lack of polyphenol analysis and oxidative stress biomarkers. Conceivably, there are a number of mechanisms that could contribute to the physiological effects exerted by MC, and further research is needed to address the underlying mechanisms for these observations. In addition, participants in the current study were asked to adhere to strict dietary guidelines in the days preceding the trials, and future work should attempt to investigate the potential synergetic effects of MC supplementation within habitual dietary practices.
In conclusion, this study has shown that acute supplementation with MC juice can lower blood pressure and improve exercise performance, specifically end-sprint performance, in trained endurance cyclists. There were no changes in plasma [NO 2 − ], pulmonary V O 2 , or muscle oxygenation after ingesting tart cherry juice so the improvements in blood pressure and exercise performance in this study might be mediated through the potent antioxidant properties of MC juice. The results of this study suggest that supplementation with MC concentrate might represent, a practical, non-pharmacological, dietary intervention to reduce blood pressure and enhance end-sprint performance in trained individuals.
| PERSPECTIVES
The improvement in end-sprint performance in the current study could prove advantageous in sporting situations where very little separates opponents. After completing exercise that was deemed metabolically strenuous, participants performed better over a 60-seconds sprint when supplemented with MC compared to placebo. Consequently, MC supplementation might be of interest to athletes, coaches, and applied sports scientists. Also, the marked reduction in systolic blood pressure we observed with MC supports previous studies 10, 11 and underlines the potential importance of MC as an adjunct to the management of hypertension. The Cherry Research Committee of the Cherry Marketing Institute (Lansing, MI, USA), a not-for-profit organization, provided support for a PhD studentship associated with this work. All other elements of the study were funded by Northumbria University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflict of interest. 
